» Articles » PMID: 24067385

Association Between Subcutaneous White Adipose Tissue and Serum 25-hydroxyvitamin D in Overweight and Obese Adults

Overview
Journal Nutrients
Date 2013 Sep 27
PMID 24067385
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Cholecalciferol is known to be deposited in human adipose tissue, but it is not known whether 25-hydroxyvitamin D (25(OH)D) is found in detectable concentrations. Therefore, our objective was to determine whether 25(OH)D is detectable in subcutaneous white adipose tissue (SWAT) in overweight and obese persons enrolled in a twelve week energy restricted diet. Baseline and post-intervention gluteal SWAT biopsies were collected from 20 subjects participating in a larger clinical weight loss intervention. LC-MS/MS was utilized to determine SWAT 25(OH)D concentrations. Serum 25(OH)D and 1,25(OH)2D were measured by RIA. Body composition was assessed by dual energy x-ray absorptiometry. SWAT 25(OH)D concentrations were 5.8 ± 2.6 nmol/kg tissue and 6.2 ± 2.7 nmol/kg tissue pre- and post-intervention SWAT, respectively. There was a significant positive association between SWAT 25(OH)D concentration and serum 25(OH)D concentration (r = 0.52, P < 0.01). Both SWAT and serum 25(OH)D concentrations did not significantly change after a twelve-week period of energy restriction with approximately 5 kg of fat loss. In conclusion, we have demonstrated our LC-MS/MS method can detect 25(OH)D3 in human subcutaneous fat tissue from overweight and obese individuals and is consistent with previously reported concentrations in swine. Additionally, our findings of no significant changes in SWAT 25(OH)D3 or serum 25(OH)D after a 6% loss of total body weight and 13% reduction in total fat provides the first human evidence that adipose 25(OH)D does not likely contribute to serum 25(OH)D with moderate weight loss; whether this is also the case with larger amounts of weight loss is unknown. Weight loss alone is not sufficient to increase serum 25(OH)D and increases in dietary or dermal biosynthesis of vitamin D appear to be the most critical contributors to in vitamin D status.

Citing Articles

Vitamin D Enhancement of Adipose Biology: Implications on Obesity-Associated Cardiometabolic Diseases.

Lee M Nutrients. 2025; 17(3).

PMID: 39940444 PMC: 11820181. DOI: 10.3390/nu17030586.


Vitamin D beyond the blood: Tissue distribution of vitamin D metabolites after supplementation.

Shadid I, Guchelaar H, Weiss S, Mirzakhani H Life Sci. 2024; 355:122942.

PMID: 39134205 PMC: 11371480. DOI: 10.1016/j.lfs.2024.122942.


An Overview of Different Vitamin D Compounds in the Setting of Adiposity.

Spyksma E, Alexandridou A, Mai K, Volmer D, Stokes C Nutrients. 2024; 16(2).

PMID: 38257127 PMC: 10820956. DOI: 10.3390/nu16020231.


Interplay between Vitamin D and Adipose Tissue: Implications for Adipogenesis and Adipose Tissue Function.

Lu S, Cao Z Nutrients. 2023; 15(22).

PMID: 38004226 PMC: 10675652. DOI: 10.3390/nu15224832.


Vitamin D status in non-pregnant women of reproductive age: a study in Southern Thailand.

Jaruratanasirikul S, Boonrusmee S, Kasemsripitak S, Saengkaew T, Chimrung K, Sriplung H Sci Rep. 2023; 13(1):15264.

PMID: 37709920 PMC: 10502050. DOI: 10.1038/s41598-023-42557-5.


References
1.
Drincic A, Armas L, Van Diest E, Heaney R . Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012; 20(7):1444-8. DOI: 10.1038/oby.2011.404. View

2.
Lagunova Z, Porojnicu A, Lindberg F, Hexeberg S, Moan J . The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009; 29(9):3713-20. View

3.
Aronov P, Hall L, Dettmer K, Stephensen C, Hammock B . Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2008; 391(5):1917-30. PMC: 3587164. DOI: 10.1007/s00216-008-2095-8. View

4.
Arunabh S, Pollack S, Yeh J, Aloia J . Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003; 88(1):157-61. DOI: 10.1210/jc.2002-020978. View

5.
Cheng S, Massaro J, Fox C, Larson M, Keyes M, McCabe E . Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2009; 59(1):242-8. PMC: 2797928. DOI: 10.2337/db09-1011. View